| Company Name: |
Sichuan Kulinan Technology Co., Ltd
|
| Tel: |
400-1166-196 18981987031 |
| Email: |
cdhxsj@163.com |
| Products Intro: |
Product Name:A5'P55'A SODIUM SALT
CAS:4097-04-5
Purity:99% HPLC Package:10g;50g;100g;500g;1kg;5kg;25kg
|
| Company Name: |
9ding chemical ( Shanghai) Limited
|
| Tel: |
4009209199 |
| Email: |
sales@9dingchem.com |
| Products Intro: |
Product Name:P1,P5-Di(adenosine-5′) pentaphosphate pentasodiuM
CAS:4097-04-5
Purity:96%
|
|
| | A[5']P5[5']A SODIUM SALT Basic information |
| Product Name: | A[5']P5[5']A SODIUM SALT | | Synonyms: | A[5']P5[5']A SODIUM SALT;P1,P5-DI(ADENOSINE-5') PENTAPHOSPHATE SODIUM SALT;Adenosine 5'-(hexahydrogen pentaphosphate), 5'->5'-ester with adenosine, pentasodium salt;P1,P5-DI(ADENOSINE-5') PENTAPHOSPHATESOD IUM;P1,P5-di(adenosine-5')pentaphosphate pentasodium salt 5H2O;Adenosine-5'-pentaphosphateε-5'-adenosyl α,β,γ,δ,ε-pentasodium salt;A(5′)P5(5′)A;Diadenosine pentaphosphate pentasodium salt | | CAS: | 4097-04-5 | | MF: | C20H24N10Na5O22P5 | | MW: | 1026.28 | | EINECS: | 223-852-7 | | Product Categories: | | | Mol File: | 4097-04-5.mol | ![A[5']P5[5']A SODIUM SALT Structure](CAS/GIF/4097-04-5.gif) |
| | A[5']P5[5']A SODIUM SALT Chemical Properties |
| storage temp. | -20°C | | solubility | H2O: 50 mg/mL | | form | powder | | color | white to white with yellow cast | | biological source | synthetic (organic) | | Water Solubility | H2O: 50mg/mL | | BRN | 4949216 | | InChIKey | NNMFUJJMJIYTSP-CSMIRWGRSA-I |
| WGK Germany | 3 | | F | 10-21 | | Storage Class | 11 - Combustible Solids |
| | A[5']P5[5']A SODIUM SALT Usage And Synthesis |
| Uses | P1,P5-Di(adenosine-5′) pentaphosphate pentasodium salt has been used as:
- an adenylate kinase (AK) inhibitor in: sarcoma osteogenic (Saos-2) cells
- mitochondrial lysates during ATP synthesis
- tetramethylrhodamine methyl ester (TMRM) based membrane potential assay
- chromoplasts
| | General Description | P1,P5-Di(adenosine-5′) pentaphosphate (Ap5A) is a diadenosine polyphosphate, which has a tail-to-tail dimer structure. Ap5A is synthesized in a twostep process involving the formation of adenosine 5′-tetraphosphate (P4A) from the ATP and trimeta-phosphate (P3). In the second step, P4A is converted to Ap5A. The synthesis of Ap5A requires a pH optimum in the range of 7.5 to 8.5 and is modulated by metal ions. | | Biochem/physiol Actions | A diadenosine polyphosphate stored in secretory granules of thrombocytes, chromaffin and neuronal cells. After release into the extracellular space, it affects a variety of biological activities in a wide range of target tissues. In the nervous system it acts through various purinergic receptors. It also activates 5′-nucleotidase and inhibits adenosine kinase activity in vitro. Ap5A is metabolized by soluble enzymes in the blood plasma and by membrane-bound ectoenzymes of a number of cell types including endothelial and smooth muscle cells. In cardiac muscle, pM to nM concentrations significantly increase the open-probability of ryanodine-receptor (RyR2) gates, with prolonged action due to slow dissociation from the receptor. | | IC 50 | Human Endogenous Metabolite |
| | A[5']P5[5']A SODIUM SALT Preparation Products And Raw materials |
|